*Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

†Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada

‡Cancer Axis, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada

§Department of Human Genetics, McGill University, Montreal, Canada

∥Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec

¶Research Pathology Facility, Lady Davis Institute, Jewish General Hospital, Montreal, Canada

#Department of Pediatric Laboratory Medicine, Hospital for Sick Children, Toronto

**Department of Pathology, McGill University Health Centre, Montreal, QC, Canada

††Institute of Pathology, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand

‡‡Department of Pathology and Chulalongkorn GenePRO Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

This work was funded by a Canadian Institutes of Health Research Grant to WDF (FDN 148390) and the Research Institute McGill University Health Centre Studentship and Fellowship to ALC.

Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Correspondence: William D. Foulkes, MBBS, PhD, Department of Specialized Medicine, Division of Medical Genetics, The Lady Davis Institute, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, QC H3T 1E2, Canada (e-mail: [email protected]).